PURPOSE
To evaluate the effect of 3 months vs. 8 months of neoadjuvant hormonal therapy before conventional dose radiotherapy (RT) on disease-free survival using prostate-specific antigen PSA and… (More)
In 2002 we fully implemented clinically a commercial Monte Carlo based treatment planning system for electron beams. The software, developed by MDS Nordion (presently Nucletron), is based on… (More)
PURPOSE AND BACKGROUND
To determine a prostatic-specific antigen (PSA) nadir value and time to nadir that predict a high probability of freedom from biochemical failure in men treated with external… (More)
Therapeutic irradiation of fields containing cardiac pacemakers presents a unique problem to pacemaker physicians and radiation oncologists alike. The present case involved a proposed radiation field… (More)
The purpose of this study was to determine if prostate specific antigen density (PSAD) is a predictor of outcome following external beam radiotherapy for prostate cancer, and to compare it with other… (More)